Glutamate-modulating drugs & the treatment of mental disorders.
Howland
Robert H
RH
University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pennsylvania 15213, USA. HowlandRH@upmc.edu
D000077443:Acamprosate; D000547:Amantadine / Q000494:pharmacology / Q000627:therapeutic use; D003523:Cycloserine / Q000494:pharmacology / Q000627:therapeutic use; D018698:Glutamic Acid / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D007649:Ketamine / Q000494:pharmacology / Q000627:therapeutic use; D000077213:Lamotrigine; D008559:Memantine / Q000494:pharmacology / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy* / Q000503:physiopathology*; D011619:Psychotropic Drugs / Q000494:pharmacology* / Q000627:therapeutic use*; D019782:Riluzole / Q000494:pharmacology / Q000627:therapeutic use; D013654:Taurine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014227:Triazines / Q000494:pharmacology / Q000627:therapeutic use
D011619:Psychotropic Drugs; D014227:Triazines; D013654:Taurine; D018698:Glutamic Acid; D007649:Ketamine; D019782:Riluzole; D003523:Cycloserine; D000547:Amantadine; D000077443:Acamprosate; D000077213:Lamotrigine; D008559:Memantine